Although α6β4 integrin signals stimulate NFAT activity in breast cancer (Jauliac et al, 2002), we now identify that NFAT is activated by oncogenic BRAF signalling, which is the most frequently mutated gene in melanoma and a gene frequently mutated in many other cancers. This evidence concerns the gene BRAF and breast carcinoma.